In vivo, the role of TREM1 has been characterized in experimental murine models of microbial sepsis, infection with influenza virus, Leishmania major and other bacterial infections, in which suppression of TREM1 signaling conferred significant protection [43–45]. This evidence concerns the gene TREM1 and bacterial infectious disease.